Casey Woodring
Stock Analyst at JP Morgan
(1.07)
# 2,785
Out of 4,496 analysts
24
Total ratings
33.33%
Success rate
-10.14%
Average return
Main Sectors:
8 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QGEN Qiagen | Maintains: Overweight | $52 → $54 | $41.55 | +29.96% | 4 | Jun 18, 2024 | |
| OSUR OraSure Technologies | Maintains: Neutral | $7 → $6 | $4.20 | +42.86% | 3 | May 13, 2024 | |
| HOLX Hologic | Maintains: Overweight | $85 → $91 | $78.11 | +16.50% | 3 | May 3, 2024 | |
| CRL Charles River Laboratories International | Maintains: Overweight | $270 → $280 | $218.24 | +28.30% | 4 | Feb 15, 2024 | |
| QDEL QuidelOrtho | Downgrades: Underweight | $66 → $37 | $34.69 | +6.66% | 3 | Feb 14, 2024 | |
| ICLR ICON PLC | Maintains: Overweight | $295 → $330 | $329.70 | +0.09% | 3 | Dec 20, 2023 | |
| EGBN Eagle Bancorp | Maintains: Neutral | $25 → $23 | $22.23 | +3.46% | 2 | Oct 31, 2023 | |
| SHC Sotera Health Company | Upgrades: Neutral | $6 → $18 | $13.09 | +37.51% | 2 | Jan 23, 2023 |
Qiagen
Jun 18, 2024
Maintains: Overweight
Price Target: $52 → $54
Current: $41.55
Upside: +29.96%
OraSure Technologies
May 13, 2024
Maintains: Neutral
Price Target: $7 → $6
Current: $4.20
Upside: +42.86%
Hologic
May 3, 2024
Maintains: Overweight
Price Target: $85 → $91
Current: $78.11
Upside: +16.50%
Charles River Laboratories International
Feb 15, 2024
Maintains: Overweight
Price Target: $270 → $280
Current: $218.24
Upside: +28.30%
QuidelOrtho
Feb 14, 2024
Downgrades: Underweight
Price Target: $66 → $37
Current: $34.69
Upside: +6.66%
ICON PLC
Dec 20, 2023
Maintains: Overweight
Price Target: $295 → $330
Current: $329.70
Upside: +0.09%
Eagle Bancorp
Oct 31, 2023
Maintains: Neutral
Price Target: $25 → $23
Current: $22.23
Upside: +3.46%
Sotera Health Company
Jan 23, 2023
Upgrades: Neutral
Price Target: $6 → $18
Current: $13.09
Upside: +37.51%